美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

VanEck Biotech ETF

235.52

+4.351.88%

成交量：2,486

成交額：58.54萬

市值：4.73億

市盈率：- -

高：236.12

開：235.95

低：235.52

收：231.17

52周最高：244.35

52周最低：160.91

股本：200.65萬

流通股本：200.65萬

量比：0.78

換手率：0.12%

股息：0.95

股息率：0.40%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

數據簡報-隨着競爭日趨激烈，減肥藥開發商紛紛搶佔這一利潤豐厚的市場

歐洲藥品管理局啓動分階段審評，加速評估Revolution Medicines的Daraxonrasib

歐洲藥品管理局（EMA）對Revolution Medicines實驗性胰腺癌口服藥啓動滾動審查

歐盟監管機構開始對一種抗癌藥物進行分階段審查，Revolution Medicines股價上漲

數據簡報-過去十年間美國製藥企業和生物技術公司參與的重大交易

每日特惠-併購

美股異動丨Crinetics盤前暴升逾99%，獲福泰製藥斥100億美元溢價超一倍收購

100億美元砸出史上最大收購：福泰製藥(VRTX.US)溢價100%收購Crinetics(CRNX.US)，殺入內分泌賽道

SEC文件披露：特定情況下交易終止，Crinetics Pharmaceuticals或需向福泰製藥支付3.5047億美元解約費

福泰製藥百億收購案引爆市場，Crinetics盤後股價翻倍飆升，終盤收漲101%至84.80美元

生物製藥公司Crinetics盤後升逾100%福泰製藥將以85美元/股收購公司。

Vertex將以100億美元收購Crinetics

Crinetics與福泰製藥交易預計2029年提升後者非GAAP運營收入

Crinetics Pharmaceuticals：融資獲美國銀行與摩根士丹利的45億美元全額承諾過橋貸款支持

福泰製藥就囊性纖維化療法Alyftrek與泛加拿大藥品聯盟簽署意向書

再生元製藥公司預計2026年第二季度GAAP及非GAAP每股攤薄收益將減少1美元——SEC文件披露

美國研究綜述-東西銀行、第一公民銀行控股公司、UMB

禮來與再生元製藥公司入選FDA首批加速新生產設施審查計劃

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/BBH/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":235.5207,"timestamp":1789668891239,"preClose":231.1734,"halted":0,"volume":2486,"delay":0,"changeRate":0.018805364284991348,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"交易中","change":4.3473,"latestTime":"09-17 14:18:35 EDT","open":235.95,"high":236.12,"low":235.5207,"amount":585364.2498,"amplitude":0.002592,"askPrice":235.76,"askSize":200,"bidPrice":235.56,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":231.1734,"sharesOutstanding":1976503,"nav":230.79718,"aum":463095224.42,"dividendRate":0.004024,"bidAskSpread":0.001036,"preHourTrading":{"tag":"盘前","latestPrice":231.03,"preClose":231.1734,"latestTime":"08:23 EDT","volume":31,"amount":7162.073219999999,"timestamp":1789647809022,"change":-0.1434,"changeRate":-0.00062,"amplitude":0.00062},"postHourTrading":{"tag":"盘后","latestPrice":231.35,"preClose":231.1734,"latestTime":"19:30 EDT","volume":14,"amount":3236.4276,"timestamp":1789601405727,"change":0.1766,"changeRate":0.000764,"amplitude":0},"volumeRatio":0.776073,"impliedVol":0.2337,"impliedVolPercentile":0.8884},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2006503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.776073,"shares":2006503,"dividePrice":0.9478,"high":236.12,"amplitude":0.002592,"preClose":231.1734,"low":235.5207,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":235.5207,"eps":0,"divideRate":0.004024,"volume":2486,"delay":0,"ttmEps":0,"open":235.95,"prevYearClose":189.2649,"prevWeekClose":229.3922,"prevMonthClose":236.396,"prevQuarterClose":203.2373,"fiveDayClose":228.6361,"twentyDayClose":244.0166,"sixtyDayClose":190.8296},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649398479","title":"數據簡報-隨着競爭日趨激烈，減肥藥開發商紛紛搶佔這一利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2649398479","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649398479?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 23:45","pubTimestamp":1783439113,"startTime":"0","endTime":"0","summary":"数据简报-随着竞争日趋激烈，减肥药开发商纷纷抢占这一利润丰厚的市场修改发稿日期；新增Viking Therapeutics和Kailera Therapeutics路透7月7日-减肥药市场正蓬勃发展，生物技术公司竞相争夺这一快速增长领域的市场份额，该领域目前主要由诺和诺德和礼来主导。辉瑞补充称，其目标是在2028年在这个快速增长的减肥药市场中获得首项批准。2024年的数据显示，在一项为期一年的中期临床试验中，MariTide帮助超重患者减重高达20% 。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4T4391HA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868837300.USD","LU0321505439.SGD","LU0203347892.USD","LU2746668461.USD","IE00BJJMRX11.SGD","THNR","IE00B2B36J28.USD","LU2750360997.AUD","SG9999014575.USD","MEDX","LU2361045086.USD","IBBQ","IE0002141913.USD","IE00BK4W5M84.HKD","PAWZ","IE00B775H168.HKD","LU0823416689.USD","LU0109394709.USD","LU2324357040.USD","LU0306806265.USD","LU1127390331.HKD","LU0098860793.USD","SG9999015952.SGD","XLV","SG9999018865.SGD","LU2491049909.HKD","IE000M9KFDE8.USD","LU0689472784.USD","LU0965509101.SGD","LU2023250330.USD","SGXZ31699556.SGD","LU0256863811.USD","LU0320765646.SGD","IE0009355771.USD","SG9999018857.SGD","OZEM","LU1814569148.SGD","LU0320765489.SGD","LU2433249047.HKD","LU1069347547.HKD","LU1037948541.HKD","LU2242646821.SGD","BK4534","LU1232071149.USD","LLYX","LU0094547139.USD","LU1720051017.SGD","HRTS","IE00BSNM7G36.USD","NVOX","LU2468319806.SGD","IE0001KFT4U8.USD","SG9999014898.SGD","BIB","IHE","IE00B3T34201.USD","LU1988902786.USD","LU2237438978.USD","LU2265009873.SGD","LLII","BK4568","LU2023250504.SGD","LU2168564065.EUR","LU2596442595.SGD","LU0942090050.USD","LU0965509283.SGD","LU0980610538.SGD","LU2491050154.USD","LU1923622614.USD","IE0004445015.USD","LU0225284248.USD","LU1323610961.USD","BK4585","LU0672654240.SGD","SG9999014914.USD","LU1066053197.SGD","LU1057294990.SGD","LU2211815571.USD","NVOH","LU1868836757.USD","AGNG","LU0859254822.USD","LU1201861249.SGD","LU1934455277.USD","LU2108987350.USD","LU0985481810.HKD","IXJ","LU2028103732.USD","LU2750360641.GBP","SGXZ57979304.SGD","ILDR","LU1983299246.USD","LU2461242641.AUD","IE00BN8TJ469.HKD","LU1093756325.SGD","LU1974910355.USD","BK4588","LU0683600562.USD","LU0225771236.USD","LU1804176565.USD","LU1883839398.USD","LU2471134952.CNY","LU2896262040.SGD","LU1894683264.USD","LU0648001328.SGD","BK4532","LU2213496289.HKD","LU2471134879.HKD","IE0002270589.USD","LU1116320901.HKD","IE00BBT3K403.USD","LU2271345857.HKD","SGXZ51526630.SGD","IE00BKPKM429.USD","LU2552382215.SGD","LU2089984988.USD","ELIL","LU0096364046.USD","FTXH","BK4559","IE00BZ1G4Q59.USD","LU2237443549.SGD","LU1267930730.SGD","LU0106261372.USD","LU0882574139.USD","LU2417539215.USD","LU1571399168.USD","LU0787776722.HKD","LU2125154935.USD","PPH","LU0058720904.USD","RXL","LU2756315318.SGD","SG9999014906.USD","LU2552382058.USD","LU2168564149.EUR","LU0823434740.USD","SG9999015986.USD","LU0965509010.AUD","LU0456855351.SGD","LU0943347566.SGD","IE00BK4W5L77.USD","LU0354030511.USD","BBH","SG9999014559.SGD","LU2264538146.SGD","LU0477156953.USD","LU0198837287.USD","LU2462157665.USD","IE00BN29S564.USD","LU1066051498.USD","LU1868836591.USD","IE0005OL40V9.USD","LU0321505868.SGD","SG9999001176.USD","LLYZ","LU2168563687.JPY","LU0385154629.USD","LU1037948897.HKD","MRK","LU2357305700.SGD","FHLC","SGXZ81514606.USD","LU1291159041.SGD","LU0130517989.USD","IE00BJJMRZ35.SGD","LU2456880835.USD","LU2236285917.USD","LU2471134523.USD","IE00BFSS8Q28.SGD","IE00BLSP4239.USD","PBE","ELIS","LU2361044865.SGD","LU0210536198.USD","LU0640476718.USD","LU2602419157.SGD","LU2111349929.HKD","SG9999014567.USD","LU2125909593.SGD","SG9999013999.USD","IE00BKVL7J92.USD","LU2491050071.SGD","BK4533","LU0432979614.USD","LU1712237335.SGD","LU2087625088.SGD","LU1066051225.USD","LU2023251221.USD","LU0061475181.USD","LU1551013425.SGD","LU2125154778.USD","VHT","LU2360032135.SGD","LU2471134796.USD","LU1929549753.HKD","LU0265550946.USD","LU0203201768.USD","SG9999011175.SGD","LU1699723380.USD","LLY","IE00B1BXHZ80.USD","IE00BKDWB100.SGD","LU0211331839.USD","GB00BDT5M118.USD","LU1430594728.SGD","LU0234572021.USD","LU1064131342.USD","IE00BJJMRY28.SGD","LU0320765059.SGD","LU2552382132.HKD","IE00BJLML261.HKD","LU1868836914.USD","RHHBY","SG9999015945.SGD","LU1917777945.USD","BMED","LU2361044949.HKD","LU0985320562.USD","LU0820562030.AUD","LU1989771016.USD","LU0109391861.USD","LU2112291526.USD","LU0316494557.USD","LU1035775433.USD","LU1093756168.USD","PJP","IE00B19Z3581.USD","BK4599","IE00B7KXQ091.USD","IE00BJT1NW94.SGD","IYH","LU2237443978.SGD","LU0889565916.HKD","LU0158827948.USD","LU0861579265.USD","LU2063271972.USD","LU0256863902.USD","SG9999015978.USD","IBB","LU0965508806.USD","SG9999014880.SGD","04332","LU1934455863.HKD","LU1280957306.USD","LU2089283258.USD","LU0265550359.USD","LU1623119135.USD","LU0097036916.USD","LU1162221912.USD","SG9999015341.SGD","LU2746668974.SGD","LU2242652126.USD","LU1366192091.USD","WDNA","LU0345770308.USD","LU1989772840.SGD","SG9999002224.SGD","LU1941712348.USD","PFE","BK4516","IE00BFSS7M15.SGD","LU1116320737.USD","LU2089284900.SGD","LU2168564222.USD","AMGN","LU0070302665.USD","LU0320765992.SGD","LU0203202063.USD","SG9999003800.SGD","LU0964807845.USD","LU2168564495.EUR","IE00B1XK9C88.USD","LU0868494708.USD","LU0820561909.HKD","LU0289739699.SGD","LU0882574055.USD","LU0820561818.USD","LU1023059063.AUD","LU1548497426.USD","LU0823434583.USD","CANC","BK4139","LU0868494617.USD","SG9999017495.SGD","LU2237443465.HKD","LU0345770993.USD","03165","LU0170899867.USD","IE00B4R5TH58.HKD","LU1551013342.USD","LU0006306889.USD","LU2106854487.HKD","MEDI","LU0354030438.USD","LU1989772923.USD","LU1585245621.USD","LU0466842654.USD","IE00BFTCPJ56.SGD","SGXZ99366536.SGD","LU0323591593.USD","GDOC","LU1035773651.USD","LU0471298777.SGD","SG9999001176.SGD","LU1061106388.HKD","IE00BLSP4452.SGD","BK4550","IE00B19Z3B42.SGD","LU0122379950.USD","JDOC","SG9999001440.SGD","BK4592","LU1069344957.HKD","LU0708995401.HKD","LU1720051108.HKD","IE00BWXC8680.SGD","LU0306807586.USD","LU1868837136.USD","LU0154236417.USD","IE00B4JS1V06.HKD","LU0114720955.EUR","LU1066051811.HKD","BK4007","SG9999015358.SGD","LU0417517546.SGD","LU2237443382.USD","LU2357627491.SGD","LU0471298694.HKD","LU0238689110.USD","LU1629891620.HKD","LU1145028129.USD","LU2023250843.SGD","LU0225283273.USD","LU0353189763.USD","LU0208291251.USD","LU0079474960.USD","LU0353189680.USD","LU2360106947.USD","BK4581","LU0266013472.USD","LU0158827781.USD","IE0004445239.USD","LU2125909247.SGD","LU0130102774.USD","SG9999014542.SGD","BK4566","SG9999002232.USD","LU2237443622.USD","LU0203345920.USD","LU1941712264.USD","LU0133085943.USD","LU0786609619.USD","NVO","LU2237443895.HKD","LU1894683348.USD","LU2756315664.SGD","LU1934455194.USD","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175603747","title":"歐洲藥品管理局啓動分階段審評，加速評估Revolution Medicines的Daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=1175603747","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175603747?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 21:30","pubTimestamp":1783431047,"startTime":"0","endTime":"0","summary":"欧洲药品管理局已决定通过分阶段审评程序，加快对Revolution Medicines, Inc.（股票简称：RVMD）旗下在研药物Daraxonrasib的评估进程。此举旨在缩短该潜在疗法的审评时间，使其能更早惠及患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","RVMD","BBH","PTH","CANC","IE00BFTCPJ56.SGD","IE0002141913.USD","IDNA","BK4139","IE0009355771.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649938851","title":"歐洲藥品管理局（EMA）對Revolution Medicines實驗性胰腺癌口服藥啓動滾動審查","url":"https://stock-news.laohu8.com/highlight/detail?id=2649938851","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649938851?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 21:07","pubTimestamp":1783429668,"startTime":"0","endTime":"0","summary":"欧洲药品管理局对Revolution Medicines实验性胰腺癌口服药启动滚动审查路透7月7日-欧洲药品管理局周二表示，已开始对Revolution Medicines公司针对转移性胰腺癌患者的实验性疗法RVMD.O进行滚动审查。今年5月，美国食品药品监督管理局批准了Revolution Medicines公司针对既往接受过治疗的胰腺癌患者的口服药物，允许其在获得监管批准前进行早期使用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4T43915N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","CANC","LU0320765992.SGD","IDNA","RVMD","BK4139","IE00BJT1NW94.SGD","BBH","PTH","IE0009355771.USD","LU0109394709.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649980277","title":"歐盟監管機構開始對一種抗癌藥物進行分階段審查，Revolution Medicines股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2649980277","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649980277?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 21:00","pubTimestamp":1783429252,"startTime":"0","endTime":"0","summary":"BUZZ-欧盟监管机构开始对一种抗癌药物进行分阶段审查，Revolution Medicines股价上涨7月7日-** 生物技术公司Revolution Medicines（RVMD.O）的股价在盘前交易中上涨1.3%，至192.42美元** 欧洲药品管理局表示，其人类药品专家委员会已开始对Revolution Medicines用于治疗转移性胰腺癌的试验性药物daraxonrasib进行分阶段审","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4T439159:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0889565916.HKD","PTH","IE0009355771.USD","IE00BFTCPJ56.SGD","BBH","IE00B2B36J28.USD","LU0320765992.SGD","CANC","BK4139","IE00B4R5TH58.HKD","IDNA","IE0002141913.USD","RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649896009","title":"數據簡報-過去十年間美國製藥企業和生物技術公司參與的重大交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2649896009","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649896009?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 18:10","pubTimestamp":1783419013,"startTime":"0","endTime":"0","summary":"数据简报-过去十年间美国制药企业和生物技术公司参与的重大交易在第1段和表格中补充了Vertex交易的相关细节路透7月7日-Vertex制药公司已同意以约100亿美元收购Crinetics制药公司，将其业务范围从血液疾病和疼痛领域扩展至罕见内分泌疾病领域。此举进一步丰富了过去十年间美国制药公司为获取从肿瘤学、神经学到罕见病及肥胖症等领域有前景疗法而进行的一系列备受瞩目的交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4T4390TH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU2324357040.USD","LU0109394709.USD","IE00B2B36J28.USD","SGXZ57979304.SGD","IBB","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2456880835.USD","SG9999001176.USD","IE00B4R5TH58.HKD","BK4139","LU1585245621.USD","LU1674673691.USD","LU0256863811.USD","IE00B19Z3581.USD","SG9999013999.USD","LU1035775433.USD","BBH","LU1093756325.SGD","VRTX","LU1778281490.HKD","IE0002270589.USD","BIB","IE00BJT1NW94.SGD","LU1674673428.USD","BK4007","LU0889565916.HKD","LU1093756168.USD","LU0058720904.USD","LU0061475181.USD","PBE","LU0079474960.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","IE00B894F039.SGD","BK4533","IE0002141913.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU2236285917.USD","LU2362540622.SGD","LU1430594728.SGD","LU0234570918.USD","BK4585","CRNX","BK4532","BK4567","IE00BZ9MQY76.HKD","IDNA","LU0417517546.SGD","LU0823416689.USD","IE00B19Z9P08.USD","LU1069344957.HKD","LU2362541273.HKD","LU2462157665.USD","IE00B19Z9Z06.USD","LU2237438978.USD","BK4588","LU2417539215.USD","IBBQ","LU0432979614.USD","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649986414","title":"每日特惠-併購","url":"https://stock-news.laohu8.com/highlight/detail?id=2649986414","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649986414?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 17:52","pubTimestamp":1783417941,"startTime":"0","endTime":"0","summary":"每日特惠-并购路透7月7日-截至周二0930 GMT，已报告以下收购要约、合并、收购和资产处置情况：** 阿布扎比国家石油公司分销业务< ADNOCDIST.AD > 表示，已同意收购壳牌< SHEL.L > 在南非的下游业务，交易隐含的企业价值约为10亿美元。这是该公司向海湾地区以外拓展业务以来迄今为止规模最大的海外收购。nL4N4381BQ** 总部位于佛罗里达州的赖特国家洪水保险公司已达成协议，将收购东京海上北美旗下公司——夏威夷第一保险公司的洪水保险保单组合。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4S4390SK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985489474.SGD","LU0310799852.SGD","SHEL.UK","BK4007","BRO","LU0965509010.AUD","VRTX","LU1430594728.SGD","IE0002141913.USD","LU1934455194.USD","LU2646069778.SGD","LU1674673691.USD","LU1894683264.USD","LU0211328371.USD","LU1880398554.USD","LU0553294199.USD","LU0630314457.HKD","PBE","BBH","LU2456880835.USD","LU0072461881.USD","IBBQ","IE00BZ9MQY76.HKD","BK4597","LU2362541513.USD","LU0979878070.USD","LU0417517546.SGD","LU0575583348.USD","BIB","IDNA","LU0654597011.USD","LU0368265418.SGD","LU0788109394.HKD","CRNX","LU0256331488.USD","BK4533","LU1430597077.USD","LU0757432116.USD","LU0878866978.SGD","LU1019632923.USD","LU0433182093.SGD","LU0256863811.USD","LU1069347547.HKD","LU0128525689.USD","LU0158827948.USD","LU2125154935.USD","LU0889565916.HKD","IBB","IE00B2B36J28.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649624600","title":"美股異動丨Crinetics盤前暴升逾99%，獲福泰製藥斥100億美元溢價超一倍收購","url":"https://stock-news.laohu8.com/highlight/detail?id=2649624600","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649624600?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 16:17","pubTimestamp":1783412226,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BBH","LU0823416689.USD","IE00B19Z3581.USD","LU0889565916.HKD","LU2417539215.USD","LU2456880835.USD","IE0002141913.USD","SG9999001176.USD","LU1093756325.SGD","LU0320765992.SGD","IDNA","LU1674673691.USD","IE00B19Z9P08.USD","SGXZ57979304.SGD","LU2362540622.SGD","LU2324357040.USD","LU0109394709.USD","IBB","LU1674673428.USD","LU2362541273.HKD","LU1069344957.HKD","PBE","IE00B4R5TH58.HKD","LU1093756168.USD","IE0002270589.USD","IBBQ","IE00B2B36J28.USD","BK4567","LU2236285917.USD","SG9999013999.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","LU0079474960.USD","IE00B19Z9Z06.USD","LU2362541513.USD","BK4139","BK4585","BK4588","LU0058720904.USD","BIB","LU0289739699.SGD","VRTX","IE00BZ9MQY76.HKD","LU0256863811.USD","LU1585245621.USD","BK4533","LU2237438978.USD","LU0432979614.USD","IE00B894F039.SGD","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649708736","title":"100億美元砸出史上最大收購：福泰製藥(VRTX.US)溢價100%收購Crinetics(CRNX.US)，殺入內分泌賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2649708736","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649708736?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 08:35","pubTimestamp":1783384535,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IDNA","IE00B19Z3581.USD","LU0289739699.SGD","BK4585","LU2237438978.USD","IE00BJT1NW94.SGD","LU0061475181.USD","LU2362541273.HKD","BBH","IE00B4R5TH58.HKD","LU1585245621.USD","LU0417517546.SGD","LU0823416689.USD","LU1093756325.SGD","LU1778281490.HKD","IE00BJJMRZ35.SGD","LU2324357040.USD","LU0234570918.USD","BIB","LU2456880835.USD","IE00BZ9MQY76.HKD","LU0058720904.USD","LU2362540622.SGD","BK4139","SG9999001176.SGD","LU2417539215.USD","BK4007","IBBQ","LU1674673691.USD","LU0079474960.USD","BK4533","LU0320765992.SGD","VRTX","IE0002270589.USD","LU0256863811.USD","IBB","LU0889565916.HKD","LU1093756168.USD","LU0432979614.USD","CRNX","IE00B19Z9P08.USD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","PBE","BK4588","IE00B2B36J28.USD","LU1035775433.USD","SG9999001176.USD","LU1430594728.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159544198","title":"SEC文件披露：特定情況下交易終止，Crinetics Pharmaceuticals或需向福泰製藥支付3.5047億美元解約費","url":"https://stock-news.laohu8.com/highlight/detail?id=1159544198","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159544198?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 05:22","pubTimestamp":1783372928,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件披露，Crinetics Pharmaceuticals Inc. 与福泰制药之间的交易若在特定情况下被终止，前者可能需要向后者支付高达3.5047亿美元的终止费用。该文件明确了触发这一巨额财务义务的具体情形。协议条款显示，这笔费用的支付并非自动生效，而是与特定的终止条件紧密挂钩。然而，这也同时意味着，一旦协议因规定情形破裂，Crinetics Pharmaceuticals将面临显著的财务支出。目前，市场正密切关注两家公司后续的动向以及该交易的具体进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","IE00B19Z9Z06.USD","LU2362541513.USD","LU0109394709.USD","BK4533","BK4567","BK4588","VRTX","LU2324357040.USD","LU0432979614.USD","SG9999001176.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0058720904.USD","IBBQ","SGXZ57979304.SGD","LU0289739699.SGD","LU2417539215.USD","LU0889565916.HKD","BK4585","CRNX","IDNA","IE0002270589.USD","IE00BJT1NW94.SGD","IE00B19Z9P08.USD","LU1093756325.SGD","LU1674673428.USD","LU1674673691.USD","BK4532","LU1035775433.USD","LU1093756168.USD","SG9999013999.USD","PBE","IE00BJJMRZ35.SGD","IE00B894F039.SGD","LU1778281490.HKD","BK4007","LU0079474960.USD","LU0234570918.USD","LU2236285917.USD","LU2456880835.USD","LU1069344957.HKD","LU2362541273.HKD","LU0823416689.USD","IE00BZ9MQY76.HKD","IE00B19Z3581.USD","LU1430594728.SGD","IE00B2B36J28.USD","LU0061475181.USD","LU2237438978.USD","LU0417517546.SGD","LU0256863811.USD","IE0009355771.USD","LU2362540622.SGD","BBH","LU2462157665.USD","LU1585245621.USD","IE0002141913.USD","BIB","SG9999001176.USD","BK4139","IBB","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130028229","title":"福泰製藥百億收購案引爆市場，Crinetics盤後股價翻倍飆升，終盤收漲101%至84.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130028229","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130028229?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:17","pubTimestamp":1783369041,"startTime":"0","endTime":"0","summary":"在福泰制药宣布一项价值高达100亿美元的收购协议后，Crinetics Pharmaceuticals Inc.的股价在盘后交易时段应声暴涨，涨幅超过一倍。截至最新数据，该公司股价飙升101%，报收于每股84.80美元。福泰制药的巨额收购计划，不仅彰显了其在相关治疗领域的战略雄心，也直接将收购标的Crinetics推向了资本市场的聚光灯下。对于Crinetics而言，这笔交易意味着其研发价值获得了市场顶尖参与者的高度认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","IE00BFTCPJ56.SGD","IBB","LU0079474960.USD","LU1069344957.HKD","LU1585245621.USD","LU1093756168.USD","LU0234570918.USD","IE00B894F039.SGD","LU1093756325.SGD","LU2236285917.USD","LU0289739699.SGD","LU1430594728.SGD","BK4588","LU1778281490.HKD","SG9999001176.SGD","LU2417539215.USD","IE0002141913.USD","BK4585","BK4533","BK4532","BK4139","BBH","LU0061475181.USD","LU0417517546.SGD","IE00B19Z9P08.USD","IDNA","IE00BJT1NW94.SGD","BIB","LU0432979614.USD","LU2237438978.USD","LU0823416689.USD","LU0058720904.USD","LU0109394709.USD","LU2362541513.USD","CRNX","IBBQ","LU2362541273.HKD","LU2362540622.SGD","LU0256863811.USD","PBE","LU1674673691.USD","IE00B4R5TH58.HKD","IE0002270589.USD","IE00B19Z3581.USD","LU0889565916.HKD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","SG9999013999.USD","IE0009355771.USD","LU1035775433.USD","LU1674673428.USD","IE00BZ9MQY76.HKD","IE00BJJMRZ35.SGD","BK4007","LU2456880835.USD","SGXZ57979304.SGD","VRTX","LU2462157665.USD","LU2324357040.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679149","title":"生物製藥公司Crinetics盤後升逾100%福泰製藥將以85美元/股收購公司。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679149?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:09","pubTimestamp":1783368555,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2456880835.USD","LU1093756168.USD","IBBQ","LU2462157665.USD","LU2236285917.USD","IE00B19Z3581.USD","IDNA","BK4532","LU2324357040.USD","IE00B19Z9P08.USD","BK4533","LU1035775433.USD","MRNX","LU0289739699.SGD","LU1778281490.HKD","IBB","LU0823416689.USD","LU1093756325.SGD","IE00BJT1NW94.SGD","BBP","BIB","SG9999001176.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","VRTX","LU0061475181.USD","BK4139","LU1585245621.USD","LU2362540622.SGD","LU2362541513.USD","LU1674673691.USD","LU2237438978.USD","SGXZ57979304.SGD","LU0320765992.SGD","BK4585","LU2417539215.USD","PBE","LU1674673428.USD","SG9999013999.USD","LU0079474960.USD","UUP","BK4588","IE00BJJMRZ35.SGD","LU2362541273.HKD","MRNY","IE0002141913.USD","BBH","UDN","IE00B19Z9Z06.USD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679469","title":"Vertex將以100億美元收購Crinetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679469","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679469?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:08","pubTimestamp":1783368527,"startTime":"0","endTime":"0","summary":"Vertex将以100亿美元收购Crinetics路透7月6日-Vertex Pharmaceuticals（VRTX.O）将以约100亿美元的总股权价值收购Crinetics Pharmaceuticals（CRNX.O），两家公司周一宣布了这一消息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nL4S4381BR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","LU1674673428.USD","IE00B2B36J28.USD","LU2362540622.SGD","LU0058720904.USD","BK4567","IE00B894F039.SGD","LU2237438978.USD","IE00B19Z3581.USD","LU2417539215.USD","LU0289739699.SGD","LU2456880835.USD","IBB","SG9999013999.USD","BK4139","IE00B19Z3B42.SGD","LU0320765992.SGD","IDNA","LU1778281490.HKD","IBBQ","BK4585","LU1674673691.USD","LU2236285917.USD","BK4588","LU0079474960.USD","BK4532","LU0061475181.USD","LU0432979614.USD","LU0109394709.USD","IE00BZ9MQY76.HKD","IE00BFTCPJ56.SGD","LU0417517546.SGD","LU0823416689.USD","PBE","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0002141913.USD","VRTX","IE00B19Z9P08.USD","LU1035775433.USD","BIB","LU1069344957.HKD","LU2324357040.USD","BBH","IE0002270589.USD","LU1585245621.USD","SG9999001176.SGD","CRNX","LU0256863811.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127833937","title":"Crinetics與福泰製藥交易預計2029年提升後者非GAAP運營收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1127833937","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127833937?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:07","pubTimestamp":1783368452,"startTime":"0","endTime":"0","summary":"根据最新披露的财务预测，Crinetics Pharmaceuticals Inc. 与福泰制药达成的战略合作，预计将在2029年对福泰制药的非通用会计准则运营收入产生积极贡献。\n此次交易的结构设计旨在通过长期协同效应，增强福泰制药的盈利质量。分析指出，该合作不仅将拓展福泰制药在特定治疗领域的产品管线，还可能优化其整体运营效率。市场预期，随着合作项目进入成熟阶段，其对财务指标的正面影响将逐步显现。\n财务模型显示，此次合作带来的收入增长与成本协同效应，是推动非通用会计准则运营收入提升的关键因素。投资者正密切关注交易细节及后续整合进程，以评估其长期价值创造潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","SG9999013999.USD","BBH","IE00BFTCPJ56.SGD","LU0058720904.USD","IDNA","LU0889565916.HKD","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","LU0823416689.USD","LU2362540622.SGD","BK4007","LU0109394709.USD","SG9999001176.SGD","LU2362541513.USD","IE00BJJMRZ35.SGD","PBE","LU0234570918.USD","LU1674673428.USD","IE00BZ9MQY76.HKD","LU1430594728.SGD","IE0002141913.USD","LU2236285917.USD","IE0009355771.USD","IBBQ","IE00B4R5TH58.HKD","LU1035775433.USD","IE00B894F039.SGD","LU1674673691.USD","LU1778281490.HKD","LU2462157665.USD","IE00B19Z3581.USD","LU0256863811.USD","LU2417539215.USD","IE00B19Z9Z06.USD","IE0002270589.USD","LU1069344957.HKD","BK4532","IBB","CRNX","IE00B19Z9P08.USD","BK4588","LU2456880835.USD","IE00B2B36J28.USD","BIB","LU0320765992.SGD","LU2324357040.USD","LU1093756168.USD","LU0289739699.SGD","LU2362541273.HKD","BK4585","BK4533","SGXZ57979304.SGD","VRTX","LU2237438978.USD","BK4139","LU1093756325.SGD","LU0432979614.USD","BK4567","SG9999001176.USD","LU0417517546.SGD","LU0061475181.USD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179291339","title":"Crinetics Pharmaceuticals：融資獲美國銀行與摩根士丹利的45億美元全額承諾過橋貸款支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1179291339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179291339?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:06","pubTimestamp":1783368378,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc. 的融资计划，已获得来自美国银行和摩根士丹利高级融资部门提供的总额高达45亿美元的全额承诺过桥贷款支持。这笔资金将为公司的战略推进提供坚实的财务后盾。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE0002141913.USD","IE00B19Z3581.USD","BIB","IE00B19Z3B42.SGD","LU0432979614.USD","IDNA","LU2362541513.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","VRTX","LU1035775433.USD","LU0256863811.USD","LU1585245621.USD","LU2456880835.USD","IE0009355771.USD","IE00B19Z9P08.USD","LU2462157665.USD","LU2324357040.USD","SG9999001176.USD","LU0823416689.USD","LU1093756168.USD","BK4533","LU0320765992.SGD","LU2417539215.USD","PBE","LU1069344957.HKD","LU2362540622.SGD","LU0079474960.USD","IE00B4R5TH58.HKD","LU0417517546.SGD","IE00B2B36J28.USD","LU1430594728.SGD","LU0889565916.HKD","IE00B19Z9Z06.USD","LU1674673691.USD","LU1674673428.USD","BK4532","BK4139","IE0002270589.USD","LU1093756325.SGD","LU1778281490.HKD","LU2237438978.USD","SG9999013999.USD","BK4567","IE00B894F039.SGD","LU0234570918.USD","IE00BZ9MQY76.HKD","IBBQ","CRNX","SG9999001176.SGD","LU0061475181.USD","BBH","BK4585","LU0289739699.SGD","LU2236285917.USD","SGXZ57979304.SGD","LU2362541273.HKD","LU0109394709.USD","IE00BFTCPJ56.SGD","BK4588","LU0058720904.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154393441","title":"福泰製藥就囊性纖維化療法Alyftrek與泛加拿大藥品聯盟簽署意向書","url":"https://stock-news.laohu8.com/highlight/detail?id=1154393441","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154393441?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 22:25","pubTimestamp":1783347947,"startTime":"0","endTime":"0","summary":"福泰制药与泛加拿大药品联盟就囊性纤维化治疗药物Alyftrek的潜在合作签署了意向书。此举标志着该药物在加拿大市场准入进程中的一个重要步骤，旨在为患者提供新的治疗选择。意向书的签署为后续正式协议的谈判奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","IBB","LU2237438978.USD","IE00BZ9MQY76.HKD","LU0058720904.USD","BK4567","LU0234570918.USD","IE00B19Z3581.USD","IE00B894F039.SGD","LU1585245621.USD","LU2362541273.HKD","SG9999001176.SGD","LU2362540622.SGD","VRTX","LU2417539215.USD","LU2462157665.USD","BK4533","BBH","LU0256863811.USD","SG9999013999.USD","LU1069344957.HKD","LU0109394709.USD","LU1674673428.USD","IBBQ","IE00B4R5TH58.HKD","BK4139","LU2324357040.USD","SG9999001176.USD","BK4532","IE00B19Z9Z06.USD","LU0289739699.SGD","LU1778281490.HKD","BIB","LU1035775433.USD","LU2236285917.USD","LU2456880835.USD","IE0002270589.USD","LU1430594728.SGD","PBE","IE00BFTCPJ56.SGD","LU2362541513.USD","BK4585","LU1093756168.USD","BK4588","LU0079474960.USD","LU0823416689.USD","LU0417517546.SGD","SGXZ57979304.SGD","LU0061475181.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","IDNA","IE0002141913.USD","IE00B19Z3B42.SGD","IE00B2B36J28.USD","IE0009355771.USD","LU1093756325.SGD","IE00B19Z9P08.USD","LU1674673691.USD","LU0320765992.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132494711","title":"再生元製藥公司預計2026年第二季度GAAP及非GAAP每股攤薄收益將減少1美元——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1132494711","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132494711?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 19:03","pubTimestamp":1783335796,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的文件，再生元制药公司（Regeneron Pharmaceuticals）预计，其2026年第二季度的美国通用会计准则（GAAP）及非美国通用会计准则（Non-GAAP）每股摊薄收益将出现下降，减少幅度约为1美元。这一预期反映了公司在特定时期内的财务表现可能面临的调整或挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU0823416689.USD","IBB","BBH","IBBQ","LU0109394709.USD","LU2362541273.HKD","LU0053666078.USD","LU0058720904.USD","BK4139","REGN","LU2237438978.USD","LU0882574055.USD","LU0823434583.USD","LU0823434740.USD","LU1917777945.USD","LU0889565916.HKD","LU2468319806.SGD","LU2106854487.HKD","LU0114720955.EUR","LU0320765992.SGD","BK4585","LU2023250504.SGD","LU2362541513.USD","LU2362540622.SGD","LU2089984988.USD","LU1974910355.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649644013","title":"美國研究綜述-東西銀行、第一公民銀行控股公司、UMB","url":"https://stock-news.laohu8.com/highlight/detail?id=2649644013","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649644013?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 16:22","pubTimestamp":1783326173,"startTime":"0","endTime":"0","summary":"美国研究综述-东西银行、第一公民银行控股公司、UMB路透7月6日-周一，华尔街证券分析师下调了多家在美国上市公司的评级和目标股价，其中包括东西银行、第一公民银行控股公司和UMB金融公司。股票条目按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nL4S4380GO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HBAN","AGMI","GILD","ADP","IQV","NEMG","PJP","ZION","QABA","FTXH","NEM","ABBV","BIIB","USB","UNHW","MRK","PBLS","IHE","PFE","MEDI","BBH","SOC","FRBT","EKG","IBB","CCB","DLTR","UNH","UNHG","OZK","PAWZ","CFR","EWBC","EROC","FCNCA","DFNL","FLG","IHF","RGLD","UMBF","AGNG","JNJ","REGN","WTFC","CBSH","ZTS","PNFP","XLV","CVS","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142675479","title":"禮來與再生元製藥公司入選FDA首批加速新生產設施審查計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1142675479","media":"投资观察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142675479?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 15:15","pubTimestamp":1783322114,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）近日启动了一项旨在加速新生产设施审查的倡议，而制药巨头礼来与再生元制药公司成为首批入选该计划的企业。此举旨在通过优化监管流程，缩短创新药物生产设施从建设到获批投产的时间，从而更快地将关键疗法推向市场。\n对于礼来和再生元而言，参与此计划意味着其未来新建或扩建的生产基地可能获得FDA更优先、更高效的审查。在当前全球生物制药竞争日益激烈的背景下，提升产能布局的敏捷性至关重要，尤其是在糖尿病、肥胖症、癌症及炎症性疾病等需求旺盛的治疗领域。这一监管合作模式有望成为行业加速发展的新催化剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLYZ","LU2028103732.USD","LU0106261372.USD","LU0353189680.USD","LU2089283258.USD","LU0889565916.HKD","IE00BK4W5L77.USD","LU2471134952.CNY","LU2552382215.SGD","SG9999014914.USD","FHLC","SG9999015952.SGD","IE00BJJMRX11.SGD","LU0114720955.EUR","IE00BJLML261.HKD","LU0466842654.USD","BK4585","LU0820562030.AUD","IE00B1XK9C88.USD","LU2237443622.USD","LU2237443895.HKD","IE00BJJMRY28.SGD","SGXZ81514606.USD","LU2491050154.USD","HRTS","LLYX","IE00BK4W5M84.HKD","LU1280957306.USD","LU0158827781.USD","LU2168563687.JPY","LU2468319806.SGD","LU1093756325.SGD","FTXH","SG9999015945.SGD","LU0708995401.HKD","LU2108987350.USD","IE0004445239.USD","LU0882574055.USD","IBB","CURE","LU0345770308.USD","LU0096364046.USD","LU0109391861.USD","LU2471134879.HKD","LU2750360641.GBP","LU0417517546.SGD","GDOC","LU2237443465.HKD","LU2362540622.SGD","LU0882574139.USD","LU0198837287.USD","WDNA","IE00BJJMRZ35.SGD","LU0006306889.USD","LU0256863902.USD","LU0289739699.SGD","LU0345770993.USD","LU0820561909.HKD","LU2361044865.SGD","LU2213496289.HKD","BK4581","LU1127390331.HKD","MEDI","LU0097036916.USD","LU0456855351.SGD","BK4588","LU0158827948.USD","LU0820561818.USD","LU0964807845.USD","PPH","LU0823416689.USD","LU1623119135.USD","BK4534","LU0225283273.USD","SGXZ57979304.SGD","LU1629891620.HKD","LU0432979614.USD","LU1720051108.HKD","LU2023251221.USD","LU1145028129.USD","IE00B2B36J28.USD","IE00B4JS1V06.HKD","LU2023250330.USD","LU0640476718.USD","LU1035775433.USD","LU2461242641.AUD","LU1232071149.USD","BK4533","JDOC","ELIS","ILDR","LU0256863811.USD","LU2211815571.USD","LU2361044949.HKD","IBBQ","LU1023059063.AUD","IE00B7KXQ091.USD","IE0002141913.USD","LU0109394709.USD","LU0061475181.USD","LU0210536198.USD","BK4516","LU2756315318.SGD","LU2417539215.USD","LU0266013472.USD","SG9999014880.SGD","LU2168564065.EUR","IXJ","MEDX","LU2896262040.SGD","LU1551013425.SGD","LU2271345857.HKD","IE00BN29S564.USD","LU2089284900.SGD","LU1323610961.USD","LU2106854487.HKD","LU1551013342.USD","LU1974910355.USD","LU2264538146.SGD","LU2491050071.SGD","IE0001KFT4U8.USD","IE00BFTCPJ56.SGD","LU1868836591.USD","LU2168564149.EUR","LU2324357040.USD","LU0354030438.USD","LU2265009873.SGD","SG9999013999.USD","LU0316494557.USD","LLY","LU2602419157.SGD","LU0122379950.USD","LU0133085943.USD","LU0203201768.USD","LU0471298777.SGD","LU1988902786.USD","LU2089984988.USD","IE00BKDWB100.SGD","SG9999001176.USD","REGN","SG9999018865.SGD","SG9999014898.SGD","LU1868836914.USD","SG9999014906.USD","LU0471298694.HKD","LU2237443549.SGD","IYH","LU0823434583.USD","XLV","LU2746668974.SGD","SGXZ99366536.SGD","LU1061106388.HKD","LU0787776722.HKD","LU2362541513.USD","LU2471134796.USD","IHE","SGXZ31699556.SGD","LU2471134523.USD","LU2112291526.USD","LU0786609619.USD","LU1057294990.SGD","LU0058720904.USD","LU2456880835.USD","IE0009355771.USD","LU0353189763.USD","LU1868837300.USD","LU2168564222.USD","LU2237438978.USD","LU2746668461.USD","LU0094547139.USD","LU2237443978.SGD","LU2063271972.USD","LU2362541273.HKD","LU1069344957.HKD","LU0234572021.USD","LU0203202063.USD","LU1064131342.USD","ELIL","PJP","LU2168564495.EUR","LU1814569148.SGD","IE00BWXC8680.SGD","LU1804176565.USD","LU2491049909.HKD","RXL","LU0672654240.SGD","LU2552382132.HKD","BBH","SG9999015986.USD","LU0943347566.SGD","IE0005OL40V9.USD","LU1989771016.USD","LLII","LU0689472784.USD","LU2750360997.AUD","SG9999015978.USD","SG9999018857.SGD","IE00B775H168.HKD","LU0053666078.USD","SGXZ51526630.SGD","BK4007","IE00BFSS7M15.SGD","IE0004445015.USD","LU2361045086.USD","SG9999001176.SGD","LU1548497426.USD","LU1093756168.USD","LU0238689110.USD","GB00BDT5M118.USD","LU1917777945.USD","LU2360106947.USD","IE00B1BXHZ80.USD","LU1868836757.USD","LU1267930730.SGD","LU2756315664.SGD","LU0323591593.USD","AGNG","IE00BJT1NW94.SGD","LU0823434740.USD","SG9999017495.SGD","LU2357305700.SGD","IE00BKPKM429.USD","LU1720051017.SGD","VHT","LU2087625088.SGD","LU0320765992.SGD","IE00BFSS8Q28.SGD","LU2237443382.USD","BK4139","CANC","LU2236285917.USD","OZEM","LU1366192091.USD","LU1868837136.USD","BK4599","LU1712237335.SGD","LU2552382058.USD","LU2023250504.SGD","LU2111349929.HKD","LU0683600562.USD","LU0079474960.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU0385154629.USD","LU1291159041.SGD","LU1983299246.USD","THNR","LU0354030511.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":198,"code":"91000000","status":"200"}]}}